Auranofin (AUR) is an orally available lipophilic gold-based anti-inflammatory compound
used for the treatment of rheumatoid arthritis (RA). Recent evidence indicates that AUR may …

The gold drugs, gold sodium thiomalate (Myocrisin), aurothioglucose (Solganal), and the
orally administered auranofin (Ridaura), are utilized in modern medicine for the treatment of …

Multidrug resistance (MDR) is a significant issue associated with the clinical application of
antibiotics. It is also challenging to discover and develop new antibiotics with novel …

Auranofin is a gold (I)-based pharmaceutical for the treatment of rheumatoid arthritis.
Despite the fact that it has been used since the 1970s, its mode of action is still not fully …

More than 30 years ago, auranofin was developed for the treatment of rheumatoid arthritis
as a substitution for the injectable gold compounds aurothiomalate and aurothioglucose …

Gold compounds have a long history of use in medicine. Auranofin was developed more
than 30 years ago as an oral therapy for rheumatoid arthritis. Now, however, auranofin is …

Nowadays, gold compounds constitute a family of very promising experimental agents for
cancer treatment. Indeed, several gold (I) and gold (III) compounds were shown to manifest …

Gold (I) complexes are an important tool in the arsenal of established approaches for
treating rheumatoid arthritis (RA), while some recent studies have suggested that gold …

The application of gold in medicine can be traced back several thousand years and Au (i)
compounds have been used in the treatment of rheumatoid arthritis since the last century …

In recent years, a few successful attempts were made to repurpose the clinically approved
antiarthritic gold drug, Auranofin (AF), as an anticancer agent. The present study shows that …